Additively manufactured medical products – the FDA perspective

Journal Title: 3D Printing in Medicine - Year 2016, Vol 2, Issue

Abstract

Additive manufacturing/3D printing of medical devices is becoming more commonplace, a 3D printed drug is now commercially available, and bioprinting is poised to transition from laboratory to market. Despite the variety of technologies enabling these products, the US Food and Drug Administration (FDA) is charged with protecting and promoting the public health by ensuring these products are safe and effective. To that end, we are presenting the FDA’s current perspective on additive manufacturing/3D printing of medical products ranging from those regulated by the Center for Devices and Radiological Health (CDRH), the Center for Drug Evaluation and Research (CDER), and the Center for Biologics Evaluation and Research (CBER). Each Center presents an overview of the additively manufactured products in their area and the specific concerns and thoughts on using this technology in those product spaces.

Authors and Affiliations

Matthew Di Prima, James Coburn, David Hwang, Jennifer Kelly, Akm Khairuzzaman, Laura Ricles

Keywords

Related Articles

Low-cost customized cranioplasty using a 3D digital printing model: a case report

Data sharing not applicable to this article as no datasets were generated or analysed during the current study.

Customized tracheal design using 3D printing of a polymer hydrogel: influence of UV laser cross-linking on mechanical properties

The use of 3D printing of hydrogels as a cell support in bio-printing of cartilage, organs and tissue has attracted much research interest. For cartilage applications, hydrogels as soft materials must show some degree of...

Low cost additive manufacturing of microneedle masters

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

Download PDF file
  • EP ID EP680667
  • DOI  10.1186/s41205-016-0005-9
  • Views 45
  • Downloads 0

How To Cite

Matthew Di Prima, James Coburn, David Hwang, Jennifer Kelly, Akm Khairuzzaman, Laura Ricles (2016). Additively manufactured medical products – the FDA perspective. 3D Printing in Medicine, 2(), -. https://europub.co.uk/articles/-A-680667